perflubron has been researched along with Myocardial Infarction in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Begovatz, P; Bönner, F; Bunke, J; Flögel, U; Grapentin, C; Jacoby, C; Kelm, M; Klingel, K; Merx, MW; Roden, M; Sager, M; Salehi Ravesh, M; Schrader, J; Schubert, R; Temme, S | 1 |
| Andre, MP; Mattrey, RF | 1 |
3 other study(ies) available for perflubron and Myocardial Infarction
| Article | Year |
|---|---|
Monocyte imaging after myocardial infarction with 19F MRI at 3 T: a pilot study in explanted porcine hearts.
Topics: Animals; Contrast Media; Crown Ethers; Fluorine-19 Magnetic Resonance Imaging; Fluorocarbons; Gadolinium; Hydrocarbons, Brominated; Imaging, Three-Dimensional; Monocytes; Myocardial Infarction; Nanoparticles; Pilot Projects; Signal-To-Noise Ratio; Swine | 2015 |
Ultrasonic enhancement of myocardial infarction with perfluorocarbon compounds in dogs.
Topics: Animals; Contrast Media; Coronary Vessels; Dogs; Drug Combinations; Echocardiography; Fluorocarbons; Hydrocarbons, Brominated; Hydroxyethyl Starch Derivatives; Image Enhancement; Ligation; Macrophages; Myocardial Infarction | 1984 |
Blood substitute being developed.
Topics: Blood Substitutes; Drug Approval; Fluorocarbons; Humans; Hydrocarbons, Brominated; Myocardial Infarction; Stroke; United States; United States Food and Drug Administration | 2000 |